AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17625124
Drug: Peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2a and ribavirin for 16 weeks (with pretreatment serum HCV RNA level of 400,000 IU/ml or less)
Trial: 17625124
Drug: Peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2a and ribavirin for 24 weeks (with pretreatment serum HCV RNA level of 400,000 IU/ml or less)
Trial: 11444452
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl 25 microg plus bupivacaine 1.25 mg (Group F)
Trial: 23131813
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (1.0 g sachets, 3 cups per day for 60 days)
Trial: 21281873
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (SIT)
Trial: 17077230
Drug: Increased access
RxNorm normalized name: sofosbuvir
DrugBank: Sofosbuvir (DB08934)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Increased access to emergency contraceptive pills (two packages dispensed in advance with unlimited resupply at no charge)
Trial: 27439408
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) therapy
Trial: 21647578
Drug: Org 26576
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26576 (0.1-10 mg/kg, i.v.)
Trial: 8873580
Drug: Hydrochlorothiazide (HCT2)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCT2) 24 mg daily
Trial: 26202594
Drug: Onartuzumab plus
RxNorm normalized name: Onartuzumab
DrugBank: Onartuzumab (DB11746)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onartuzumab plus placebo plus weekly paclitaxel (OP)
Trial: 17297382
Drug: Cellulose sulfate
RxNorm normalized name: CELLULOSE SULFATE
DrugBank: Microcrystalline cellulose (DB14158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose sulfate (CS) gel
Trial: 8619109
Drug: Pre-operative internal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative internal brachytherapy (two alternative doses)
Trial: 30949906
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (IAsp)
Trial: 2011924
Drug: Low-dose alpha-IFN
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose alpha-IFN (1.5 MU/day with the same schedule and for the same period)
Trial: 15198763
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (0.8 mg)
Trial: 16260342
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (0.8 mg)
Trial: 7791814
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with cyclosporine (2.5 to 5 mg per kilogram of body weight per day) and methotrexate (at the maximal tolerated dose)
Trial: 27356547
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 supplementation (50 µg)
Trial: 14586213
Drug: Bryostatin-1 120
RxNorm normalized name: Bryostatin-1
DrugBank: Bryostatin 1 (DB11752)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bryostatin-1 120 mug/m(2) as a 72-h continuous infusion every 2 weeks (Regimen II)
Trial: 7134228
Drug: Aluminium oxide
RxNorm normalized name: Aluminium oxide
DrugBank: Aluminum oxide (DB11342)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminium oxide adsorbate vaccines (54, 108, and 216 IU/dose)
Trial: 30578542
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (50,000 IU weekly for 12 weeks)
Trial: 26487300
Drug: Monthly survey
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly survey plus tailored risk reduction messages
Trial: 7615781
Drug: Inhaled beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta 2 agonist with inhaled corticosteroids
Trial: 14625122
Drug: Hormonal Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal Replacement Therapy (HRT)
Trial: 22840829
Drug: 10-week exercise
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 10-week exercise intervention program consisting of supervised weekly 60-minute sessions and unsupervised 30 minutes of aerobic exercises 4 times each week.
Trial: 10337433
Drug: Olopatadine ophthalmic
RxNorm normalized name: olopatadine ophthalmic
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olopatadine ophthalmic solution (0.1%)
Trial: 7586929
Drug: Felbamate 2400
RxNorm normalized name: Felbamate
DrugBank: Felbamate (DB00949)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felbamate 2400 mg/day
Trial: 21175801
Drug: Intragastric infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intragastric infusion of 0.1 mol/L hydrochloric acid
Trial: 27993387
Drug: Simvastatin (SIMVA)
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin (SIMVA) 20 mg/d
Trial: 9750805
Drug: Transarterial brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial brachial plexus blockade with injection of 2/3 of the anaesthetic in back of and 1/3 in front of the artery (group TAP)
Trial: 9750805
Drug: Transarterial brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial brachial plexus blockade with one single injection in back of the artery (group TP)
Trial: 8229497
Drug: Chlorpromazine alone
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine alone (30 mg/m2 given intravenously)
Trial: 10340913
Drug: Thalidomide administration
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide administration
Trial: 12753271
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CC)
Trial: 17947832
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (BSS)
Trial: 12621386
Drug: Oral cisapride
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cisapride (0.07 mg/kg)
Trial: 7842184
Drug: Intranasal triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal triamcinolone acetonide
Trial: 22807519
Drug: Balapiravir 1500
RxNorm normalized name: Balapiravir
DrugBank: Balapiravir (DB12283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balapiravir 1500 mg
Trial: 18074664
Drug: Esomeprazole magnesium
RxNorm normalized name: Esomeprazole Magnesium
DrugBank: Esomeprazole (DB00736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Esomeprazole magnesium 40 mg once daily for 2 to 12 months
Trial: 27183546
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide (FAc) implants
Trial: 9761130
Drug: I2 (iodine)
RxNorm normalized name: I2
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: I2 (iodine) at doses of 0.3 or 1 mg/kg body weight
Trial: 29571953
Drug: Control injection
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control injection of sterile saline water
Trial: 29268139
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m2 plus carboplatin AUC4
Trial: 23949578
Drug: Albuterol administration
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol administration (mean 12.3 mg prior to baseline)
Trial: 14516877
Drug: trapidil 100
RxNorm normalized name: trapidil
DrugBank: Trapidil (DB09283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trapidil 100 mg 3 times daily
Trial: 28810024
Drug: Lifestyle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle intervention (n=64) including 5 to 6 weekly aerobic training sessions (30-60 minutes) and dietary plans aiming for a BMI of 25 or less.
Trial: 8172701
Drug: Proposed evaluation
RxNorm normalized name: Propoven
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proposed evaluation method for treatment of otitis media
Trial: 25434320
Drug: Drotaverine hydrochloride
RxNorm normalized name: drotaverine hydrochloride
DrugBank: Drotaverine (DB06751)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotaverine hydrochloride 80 mg tablet given thrice a day
Trial: 28371204
Drug: Bland dimethicone-based
RxNorm normalized name: Dimethicone
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bland dimethicone-based ointment and petrolatum-based cream
Trial: 23748114
Drug: Fulranumab 10
RxNorm normalized name: Fulranumab
DrugBank: Fulranumab (DB12102)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulranumab 10 mg every 8 weeks (Q8wk)
Trial: 25708866
Drug: niacin 6000
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: niacin 6000 mg/day
Trial: 18595523
Drug: Aerius 5
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerius 5 mg/d for 12 days
Trial: 16738858
Drug: Sham subconjunctival
RxNorm normalized name: lincomycin
DrugBank: Lincomycin (DB01627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham subconjunctival injection
Trial: 12095806
Drug: Observation without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Observation without treatment (63 patients)
Trial: 26806605
Drug: SQ BNP
RxNorm normalized name: BNP
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SQ BNP 10 µg/kg, twice-daily for 12 weeks
Trial: 19029093
Drug: Priming dose
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Priming dose followed by bolus (0.06+0.94 mg kg(‐1))
Trial: 25268567
Drug: Low-dose progesterone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose progesterone (PG)
Trial: 28104702
Drug: IL-2 treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IL-2 treatment
Trial: 20130094
Drug: Low-dose DHA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose DHA (400 mg/d)
Trial: 17197130
Drug: Adequate RT
RxNorm normalized name: Adequan
DrugBank: Polysulfated glycosaminoglycan (DB11538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adequate RT (minimum radiation dose delivered: 4300 cGy for neoadjuvant RT or 4700 cGy for adjuvant RT; completion of RT in <44 days for neoadjuvant RT or <49 days for adjuvant RT)
Trial: 8807068
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ciprofloxacin and clarithromycin)
Trial: 11427639
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 mg)
Trial: 9587911
Drug: Chronic exposure
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic exposure to carbon disulfide (9.36‐23.4 mg/m2)
Trial: 22852579
Drug: Org 26576
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26576 at 450 mg bid in MDD patients
Trial: 20458090
Drug: Cholecalciferol treatment
RxNorm normalized name: Cholecalciferol
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol treatment (800 IU/d)
Trial: 7105431
Drug: L-dopa plus
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-dopa plus carbidopa (250 mg and 25 mg respectively every 6 h for 1 day)
Trial: 26525809
Drug: Axamon (ipidacrine)
RxNorm normalized name: ipidacrine
DrugBank: Ipidacrine (DB13668)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Axamon (ipidacrine) in addition to basic therapy (B vitamins, lipoic acid) for 6 weeks
Trial: 18753749
Drug: Restorations without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Restorations without leakage (L-) with fluoride dentifrice (FD)
Trial: 20039090
Drug: Procalcitonin (PCT)
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin (PCT) algorithm-guided antibiotic therapy
Trial: 19111473
Drug: Capecitabine 1000
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 1000 mg/(m2 12 h), days 1‐14 plus oxaliplatin 130 mg/m2 day 1, every 3 weeks
Trial: 8200260
Drug: Interferon-alpha 2a
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 2a therapy
Trial: 29194531
Drug: Radical rectal
RxNorm normalized name: Radicava
DrugBank: Edaravone (DB12243)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Radical rectal surgery (segmental resection)
Trial: 12846615
Drug: Low-dose bupivacaine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bupivacaine 4 mg with 25 micro g of fentanyl
Trial: 29348651
Drug: MDMA 75
RxNorm normalized name: MDMA
DrugBank: Midomafetamine (DB01454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA 75 mg
Trial: 28525555
Drug: Baclofen 180
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen 180 mg/day
Trial: 12575905
Drug: SUCROSE diet
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SUCROSE diet (high carbohydrate increase of 90 g sucrose/d)
Trial: 29570535
Drug: Testosterone supplementation
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone supplementation with testosterone enanthate injections at 2-week intervals during bed rest
Trial: 10783450
Drug: Lignocaine gel
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine gel alone
Trial: 6364951
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin
Trial: 27658130
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid supplementation (2.4 g daily for 1 month)
Trial: 25472768
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (basal-bolus)
Trial: 15053895
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin (single dose)
Trial: 30922276
Drug: Oxycodone
RxNorm normalized name: Oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone
Trial: 19951555
Drug: Glutamine-enriched enteral
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-enriched enteral nutrition (0.5 g x kg(‐1) x d(‐1))
Trial: 8503339
Drug: Flutamide 90
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 90 mg/day
Trial: 8610768
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (transdermal or oral)
Trial: 31505542
Drug: l-DOPA
RxNorm normalized name: L-dopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: l-DOPA
Trial: 25920500
Drug: Budesonide MMX
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide MMX 9 mg
Trial: 23436336
Drug: Budesonide MMX
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide MMX 6 mg
Trial: 29154068
Drug: Yoga home-exercise
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yoga home-exercise (10min daily)
Trial: 10414910
Drug: G-CSF administration
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administration on day +1 (group B)
Trial: 31313549
Drug: Vancomycin hydrochloride
RxNorm normalized name: Vancomycin Hydrochloride
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin hydrochloride 1000 mg BD
Trial: 23663488
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS) 100 μg, 1 spray/nostril QD for 4 weeks
Trial: 30076173
Drug: Gemtuzumab ozogamicin
RxNorm normalized name: Gemtuzumab Ozogamicin
DrugBank: Gemtuzumab ozogamicin (DB00056)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Gemtuzumab ozogamicin 3 mg/m2 on days 1, 4, and 7 during induction and 3 mg/m2/day on day 1 during consolidation
Trial: 9095813
Drug: Low-air loss
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-air loss (LAL) therapy
Trial: 28338531
Drug: Oral Contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Contraceptives
Trial: 25248797
Drug: Lifestyle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle intervention (weekly trainer-led group exercise sessions, instructed home exercise 3-5 times/week during 20-36 weeks of gestation, dietary counseling twice during pregnancy)
Trial: 11789241
Drug: Integrated traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated traditional Chinese and Western medicine (TCM‐WM) therapy using Jiangtang Janshenling (JTJSL) capsule, alongside western medicine for blood glucose control, for three months.
Trial: 2144260
Drug: UK 79300
RxNorm normalized name: UK-390957
DrugBank: UK-390957 (DB11719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK 79300 (25 or 50 mg p.o.)
Trial: 18777156
Drug: Insulin Aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin Aspart
Trial: 24002929
Drug: Landiolol hydrochloride
RxNorm normalized name: Landiolol Hydrochloride
DrugBank: Landiolol (DB12212)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Landiolol hydrochloride (high dose): 0.25 mg/kg/min (1 min) loading followed by 0.04 mg/kg/min (20 min) continuous infusion
Trial: 27689944
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment (0.67 mg/m2/day)
Trial: 7788682
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate (ACE inhibitor) for six weeks
Trial: 26939318
Drug: Fire-needle treatment
RxNorm normalized name: Fire Out
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fire-needle treatment
Trial: 20880870
Drug: Cylinder air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cylinder air provided at 6 l/min intranasally during activities provoking breathlessness